• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

周期素 D1 诱导 Dicer 调控乳腺癌中的 microRNA 加工和表达。

Cyclin D1 induction of Dicer governs microRNA processing and expression in breast cancer.

机构信息

1] Department of Cancer Biology, Thomas Jefferson University, 233 South 10th Street, Philadelphia, Pennsylvania 19107, USA [2] Kimmel Cancer Center, Thomas Jefferson University, 233 South 10th Street, Philadelphia, Pennsylvania 19107, USA [3] Research Center for Translational Medicine, Key Laboratory for Basic Research in Cardiology, East Hospital, Tongji University School of Medicine, 150 Jimo Road, Shanghai 200120, China.

出版信息

Nat Commun. 2013;4:2812. doi: 10.1038/ncomms3812.

DOI:10.1038/ncomms3812
PMID:24287487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3874416/
Abstract

Cyclin D1 encodes the regulatory subunit of a holoenzyme that phosphorylates the pRB protein and promotes G1/S cell-cycle progression and oncogenesis. Dicer is a central regulator of miRNA maturation, encoding an enzyme that cleaves double-stranded RNA or stem-loop-stem RNA into 20-25 nucleotide long small RNA, governing sequence-specific gene silencing and heterochromatin methylation. The mechanism by which the cell cycle directly controls the non-coding genome is poorly understood. Here we show that cyclin D1(-/-) cells are defective in pre-miRNA processing which is restored by cyclin D1a rescue. Cyclin D1 induces Dicer expression in vitro and in vivo. Dicer is transcriptionally targeted by cyclin D1, via a cdk-independent mechanism. Cyclin D1 and Dicer expression significantly correlates in luminal A and basal-like subtypes of human breast cancer. Cyclin D1 and Dicer maintain heterochromatic histone modification (Tri-m-H3K9). Cyclin D1-mediated cellular proliferation and migration is Dicer-dependent. We conclude that cyclin D1 induction of Dicer coordinates microRNA biogenesis.

摘要

周期蛋白 D1 编码全酶的调节亚基,该全酶可使 pRB 蛋白磷酸化,并促进 G1/S 细胞周期进程和肿瘤发生。Dicer 是 miRNA 成熟的核心调节剂,编码一种能够将双链 RNA 或茎环茎 RNA 切割成 20-25 个核苷酸长的小 RNA 的酶,调控序列特异性基因沉默和异染色质甲基化。细胞周期直接控制非编码基因组的机制尚不清楚。本文中我们发现,周期蛋白 D1(-/-)细胞在前 miRNA 加工中存在缺陷,而通过 cyclin D1a 挽救可恢复该过程。体外和体内实验均表明,cyclin D1 可诱导 Dicer 的表达。cyclin D1 通过一种不依赖 CDK 的机制,在转录水平上靶向 Dicer。cyclin D1 和 Dicer 的表达在人乳腺癌的腔 A 型和基底样亚型中显著相关。cyclin D1 和 Dicer 维持异染色质组蛋白修饰(Tri-m-H3K9)。cyclin D1 介导的细胞增殖和迁移依赖于 Dicer。综上,我们的结论是,cyclin D1 诱导 Dicer 协调了 miRNA 的生物发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e79e/3874416/9b5c286aca13/nihms534470f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e79e/3874416/24569c770c5f/nihms534470f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e79e/3874416/4a1efff8260b/nihms534470f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e79e/3874416/92ee1690a6ce/nihms534470f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e79e/3874416/a2232d4916b0/nihms534470f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e79e/3874416/09fa55437f8e/nihms534470f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e79e/3874416/9b5c286aca13/nihms534470f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e79e/3874416/24569c770c5f/nihms534470f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e79e/3874416/4a1efff8260b/nihms534470f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e79e/3874416/92ee1690a6ce/nihms534470f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e79e/3874416/a2232d4916b0/nihms534470f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e79e/3874416/09fa55437f8e/nihms534470f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e79e/3874416/9b5c286aca13/nihms534470f6.jpg

相似文献

1
Cyclin D1 induction of Dicer governs microRNA processing and expression in breast cancer.周期素 D1 诱导 Dicer 调控乳腺癌中的 microRNA 加工和表达。
Nat Commun. 2013;4:2812. doi: 10.1038/ncomms3812.
2
DICER1 regulated let-7 expression levels in p53-induced cancer repression requires cyclin D1.DICER1调控p53诱导的癌症抑制过程中let-7的表达水平需要细胞周期蛋白D1。
J Cell Mol Med. 2015 Jun;19(6):1357-65. doi: 10.1111/jcmm.12522. Epub 2015 Feb 20.
3
Cyclin D1-mediated microRNA expression signature predicts breast cancer outcome.Cyclin D1 介导的 microRNA 表达谱预测乳腺癌预后。
Theranostics. 2018 Mar 11;8(8):2251-2263. doi: 10.7150/thno.23877. eCollection 2018.
4
Cyclin D1 promotes secretion of pro-oncogenic immuno-miRNAs and piRNAs.周期蛋白 D1 促进致癌免疫 miRNA 和 piRNA 的分泌。
Clin Sci (Lond). 2020 Apr 17;134(7):791-805. doi: 10.1042/CS20191318.
5
CyclinD1 inhibits dicer and crucial miRNA expression by chromatin modification to promote the progression of intrahepatic cholangiocarcinoma.CyclinD1 通过染色质修饰抑制 Dicer 和关键 miRNA 的表达,从而促进肝内胆管癌的进展。
J Exp Clin Cancer Res. 2019 Oct 7;38(1):413. doi: 10.1186/s13046-019-1415-5.
6
A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation.细胞周期蛋白D1/微小RNA 17/20调控反馈环对乳腺癌细胞增殖的控制
J Cell Biol. 2008 Aug 11;182(3):509-17. doi: 10.1083/jcb.200801079.
7
EYA1 phosphatase function is essential to drive breast cancer cell proliferation through cyclin D1.EYA1 磷酸酶的功能对于通过 cyclin D1 驱动乳腺癌细胞增殖是必不可少的。
Cancer Res. 2013 Jul 15;73(14):4488-99. doi: 10.1158/0008-5472.CAN-12-4078. Epub 2013 May 1.
8
Cyclin D1 induction of cellular migration requires p27(KIP1).细胞周期蛋白D1诱导细胞迁移需要p27(KIP1)。
Cancer Res. 2006 Oct 15;66(20):9986-94. doi: 10.1158/0008-5472.CAN-06-1596.
9
Minireview: Cyclin D1: normal and abnormal functions.小型综述:细胞周期蛋白D1:正常与异常功能
Endocrinology. 2004 Dec;145(12):5439-47. doi: 10.1210/en.2004-0959. Epub 2004 Aug 26.
10
Cell cycle regulators cyclin D1 and CDK4/6 have estrogen receptor-dependent divergent functions in breast cancer migration and stem cell-like activity.细胞周期调控因子 cyclin D1 和 CDK4/6 在乳腺癌迁移和干细胞样活性中具有雌激素受体依赖性的不同功能。
Cell Cycle. 2013 Aug 1;12(15):2384-94. doi: 10.4161/cc.25403. Epub 2013 Jun 26.

引用本文的文献

1
Research and development prospects of TRIM65.TRIM65的研发前景
J Cancer Res Clin Oncol. 2025 Aug 22;151(8):232. doi: 10.1007/s00432-025-06285-9.
2
The multiple functions and mechanisms of long non-coding RNAs in regulating breast cancer progression.长链非编码RNA在调控乳腺癌进展中的多种功能及机制
Front Pharmacol. 2025 Mar 28;16:1559408. doi: 10.3389/fphar.2025.1559408. eCollection 2025.
3
TRIM65 promotes renal cell carcinoma through ubiquitination and degradation of BTG3.TRIM65 通过泛素化和 BTG3 的降解促进肾细胞癌。

本文引用的文献

1
EYA1 phosphatase function is essential to drive breast cancer cell proliferation through cyclin D1.EYA1 磷酸酶的功能对于通过 cyclin D1 驱动乳腺癌细胞增殖是必不可少的。
Cancer Res. 2013 Jul 15;73(14):4488-99. doi: 10.1158/0008-5472.CAN-12-4078. Epub 2013 May 1.
2
Inducible deletion of epidermal Dicer and Drosha reveals multiple functions for miRNAs in postnatal skin.诱导性敲除表皮 Dicer 和 Drosha 揭示了 miRNA 在出生后皮肤中的多种功能。
Development. 2012 Apr;139(8):1405-16. doi: 10.1242/dev.070920.
3
ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice.
Cell Death Dis. 2024 May 22;15(5):355. doi: 10.1038/s41419-024-06741-3.
4
Nanoparticles carrying paclitaxel and anti-miR-221 for breast cancer therapy triggered by ultrasound.携带紫杉醇和抗miR-221的纳米颗粒用于超声触发的乳腺癌治疗。
Cell Death Discov. 2023 Aug 15;9(1):298. doi: 10.1038/s41420-023-01594-9.
5
Regulation of the Cell Cycle by ncRNAs Affects the Efficiency of CDK4/6 Inhibition.ncRNAs 通过调控细胞周期影响 CDK4/6 抑制的效率。
Int J Mol Sci. 2023 May 18;24(10):8939. doi: 10.3390/ijms24108939.
6
IL11 signaling mediates piR-2158 suppression of cell stemness and angiogenesis in breast cancer.IL11 信号介导 piR-2158 抑制乳腺癌中的细胞干性和血管生成。
Theranostics. 2023 Apr 17;13(7):2337-2349. doi: 10.7150/thno.82538. eCollection 2023.
7
Cell cycle regulation and hematologic malignancies.细胞周期调控与血液系统恶性肿瘤
Blood Sci. 2019 Sep 17;1(1):34-43. doi: 10.1097/BS9.0000000000000009. eCollection 2019 Aug.
8
Oscillatory Behaviors of microRNA Networks: Emerging Roles in Retinal Development.微小RNA网络的振荡行为:在视网膜发育中的新作用
Front Cell Dev Biol. 2022 Feb 2;10:831750. doi: 10.3389/fcell.2022.831750. eCollection 2022.
9
M6A associated TSUC7 inhibition contributed to Erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way.M6A 相关的 TSUC7 抑制通过依赖 Notch 信号激活的方式导致肺腺癌对厄洛替尼产生耐药性。
J Exp Clin Cancer Res. 2021 Oct 16;40(1):325. doi: 10.1186/s13046-021-02137-9.
10
Oncogenic and Tumor Suppressive Components of the Cell Cycle in Breast Cancer Progression and Prognosis.细胞周期的致癌和抑癌成分在乳腺癌进展及预后中的作用
Pharmaceutics. 2021 Apr 17;13(4):569. doi: 10.3390/pharmaceutics13040569.
ChIP 测序分析 cyclin D1 发现其在小鼠染色体不稳定性中具有转录作用。
J Clin Invest. 2012 Mar;122(3):833-43. doi: 10.1172/JCI60256. Epub 2012 Feb 6.
4
Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response.人类胚胎干细胞中 miRNA 靶基因的全基因组鉴定揭示了 miR-302 在调节 BMP 反应中的作用。
Genes Dev. 2011 Oct 15;25(20):2173-86. doi: 10.1101/gad.17221311.
5
The Caenorhabditis elegans SOMI-1 zinc finger protein and SWI/SNF promote regulation of development by the mir-84 microRNA.秀丽隐杆线虫 SOMI-1 锌指蛋白和 SWI/SNF 促进 mir-84 微 RNA 对发育的调控。
Genes Dev. 2011 Oct 1;25(19):2079-92. doi: 10.1101/gad.17153811.
6
MicroRNA destabilization enables dynamic regulation of the miR-16 family in response to cell-cycle changes.MicroRNA 失稳使得 miR-16 家族能够响应细胞周期变化进行动态调节。
Mol Cell. 2011 Sep 16;43(6):993-1004. doi: 10.1016/j.molcel.2011.08.021.
7
When cellular networks run out of control: global dysregulation of the RNAi machinery in human pathology and therapy.当细胞网络失去控制时:人类病理学和治疗中 RNAi 机制的全球失调。
Prog Mol Biol Transl Sci. 2011;102:165-242. doi: 10.1016/B978-0-12-415795-8.00006-4.
8
miR-17~92 cooperates with RB pathway mutations to promote retinoblastoma.miR-17~92 与 RB 通路突变协同促进视网膜母细胞瘤。
Genes Dev. 2011 Aug 15;25(16):1734-45. doi: 10.1101/gad.17027411. Epub 2011 Aug 4.
9
Limiting Ago protein restricts RNAi and microRNA biogenesis during early development in Xenopus laevis.限制 Ago 蛋白在非洲爪蟾早期发育过程中限制 RNAi 和 microRNA 的生物发生。
Genes Dev. 2011 Jun 1;25(11):1121-31. doi: 10.1101/gad.2038811. Epub 2011 May 16.
10
MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer.微小 RNA-335 通过遗传和表观遗传机制抑制人类乳腺癌的肿瘤再起始和沉默。
Genes Dev. 2011 Feb 1;25(3):226-31. doi: 10.1101/gad.1974211.